To sum up, we constructed a GI-related prognostic risk model comprising six lncRNAs (U62317.4, MAPT-AS1, AC115837.2, EGOT, SEMA3B-AS1, and HOTAIR) in breast cancer. This evidence concerns the gene MAPT and breast carcinoma.